• Publications
  • Influence
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.
This part of the EFISG guidelines focuses on non-neutropenic adult patients. Only a few of the numerous recommendations can be summarized in the abstract. Prophylactic usage of fluconazole isExpand
  • 792
  • 54
  • PDF
Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic
Invasive opportunistic fungal diseases (IFDs) are important causes of morbidity and mortality in paediatric patients with cancer and those who have had an allogeneic haemopoietic stem-cellExpand
  • 260
  • 23
Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system.
The central nervous system (CNS) distribution and antifungal efficacy of all 4 approved formulations of amphotericin B (AmB) were investigated in a rabbit model of hematogenous Candida albicansExpand
  • 302
  • 21
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
The European Society for Clinical Microbiology and Infectious Diseases, the European Confederation of Medical Mycology and the European Respiratory Society Joint Clinical Guidelines focus onExpand
  • 329
  • 19
  • PDF
ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
The European Conference on Infections in Leukemia (ECIL) provides recommendations for diagnostic strategies and prophylactic, pre-emptive or targeted therapy strategies for various types of infectionExpand
  • 230
  • 16
  • PDF
Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty‐first century
  • T. Walsh, A. Groll
  • Medicine
  • Transplant infectious disease : an official…
  • 1 December 1999
Opportunistic fungi have emerged during the past decade as important causes of morbidity and mortality in immunocompromised patients. Candida species constitute the third to fourth most common causesExpand
  • 296
  • 15
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013.
These European Society for Clinical Microbiology and Infectious Diseases and European Confederation of Medical Mycology Joint Clinical Guidelines focus on the diagnosis and management ofExpand
  • 534
  • 14
  • PDF
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures.
As the mortality associated with invasive Candida infections remains high, it is important to make optimal use of available diagnostic tools to initiate antifungal therapy as early as possible and toExpand
  • 296
  • 14
  • PDF
Trends in the postmortem epidemiology of invasive fungal infections at a university hospital.
BACKGROUND Due to the continuing lack of sensitive and specific diagnostic tools, clinical data on opportunistic invasive fungal infections (IFIs) remain difficult to assess and postmortem data areExpand
  • 503
  • 13
  • PDF